Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the β-cell potassium adenosine triphosphate channel

被引:71
|
作者
Gloyn, AL
Cummings, EA
Edghill, EL
Harries, LW
Scott, R
Costa, T
Temple, IK
Hattersley, AT
Ellard, S
机构
[1] Peninsula Med Sch, Exeter EX2 5AX, Devon, England
[2] Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada
[3] IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada
[4] Univ Montreal, Hop St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada
[5] Univ Southampton, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England
[6] Univ Southampton, Div Human Genet, Southampton SO16 5YA, Hants, England
[7] Hosp Natl Hlth Serv Trust, Southampton SO16 5YA, Hants, England
来源
关键词
D O I
10.1210/jc.2004-0568
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activating mutations in the KCNJ11 gene encoding for the Kir6.2 subunit of the beta-cell ATP-sensitive potassium channel have recently been shown to be a common cause of permanent neonatal diabetes. In 80% of probands, these are isolated cases resulting from de novo mutations. We describe a family in which two affected paternal half-siblings were found to be heterozygous for the previously reported R201C mutation. Direct sequencing of leukocyte DNA showed that their clinically unaffected mothers and father were genotypically normal. Quantitative real-time PCR analysis of the father's leukocyte DNA detected no trace of mutant DNA. These results are consistent with the father being a mosaic for the mutation, which is restricted to his germline. This is the first report of germline mosaicism in any form of monogenic diabetes. The high percentage of permanent neonatal diabetes cases due to de novo KCNJ11 mutations suggests that germline mosaicism maybe common. The possibility of germline mosaicism should be considered when counseling recurrence risks for the parents of a child with an apparently de novo KCNJ11 activating mutation.
引用
收藏
页码:3932 / 3935
页数:4
相关论文
共 44 条
  • [1] Efficacy of glibenclamide treatment in a child with permanent neonatal diabetes mellitus due to a KCNJ11 (Kir6.2) mutation
    Manna, Thais D.
    Battistim, Claudilene
    Radonsky, Vanessa
    Kuperman, Hilton
    Damiani, Durval
    Kok, Fernando
    Pearson, Ewan
    Hattersley, Andrew
    Reis, Andre F.
    HORMONE RESEARCH, 2008, 70 : 245 - 245
  • [2] Long-term effect of sulfionylura in permanent neonatal diabetes due to mutations in KCNJ11 encoding kir6.2
    Njolstad, PR
    Abuelo, D
    Baevre, H
    Hansen, T
    Hathout, E
    Kirsti, A
    Hogasen, M
    Molven, A
    Pedersen, O
    Phutkul, CP
    Pontynen, S
    Pruhova, S
    Raeder, H
    Sagen, JV
    Shehadeh, N
    Silva, JML
    Sovik, O
    DIABETES, 2005, 54 : A293 - A293
  • [3] Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
    Gloyn, AL
    Pearson, ER
    Antcliff, JF
    Proks, P
    Bruining, GJ
    Slingerland, AS
    Howard, N
    Srinivasan, S
    Silva, JMCL
    Molnes, J
    Edghill, EL
    Frayling, TM
    Temple, IK
    Mackay, D
    Shield, JPH
    Sumnik, Z
    van Rhijn, A
    Wales, JKH
    Clark, P
    Gorman, S
    Aisenberg, J
    Ellard, S
    Njolstad, PR
    Ashcroft, FM
    Hattersley, AT
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18): : 1838 - 1849
  • [4] Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2 -: Patient characteristics and initial response to sulfonylurea therapy
    Sagen, JV
    Ræder, H
    Hathout, E
    Shehadeh, N
    Gudmundsson, K
    Bævre, H
    Abuelo, D
    Phornphutkul, C
    Molnes, J
    Bell, GI
    Gloyn, AL
    Hattersley, AT
    Molven, A
    Sovik, O
    Njolstad, PR
    DIABETES, 2004, 53 (10) : 2713 - 2718
  • [5] Insulin independence with sulphonylurea treatment in a series of patients with permanent neonatal diabetes due to heterozygous activating mutations in the KCNJ11 (Kir6.2) gene
    Pearson, ER
    Flechtner, I
    Ellard, S
    Robert, JJ
    Clark, PM
    Hamilton-Shield, JP
    Polak, M
    Hattersley, AT
    DIABETOLOGIA, 2005, 48 : A113 - A114
  • [6] Successful transition from insulin to glyburide in 2 siblings with neonatal diabetes mellitus due to KCNJ11 gene mutation encoding Kir6.2
    Neacsu, Otilia
    Quintos, J. B.
    Phornphutkul, Chanika
    McEachern, Rebecca R.
    HORMONE RESEARCH, 2009, 72 : 327 - 327
  • [7] Transient neonatal diabetes mellitus is associated with a R50Q mutation in the Kir6.2 subunit (KCNJ11) gene
    Ioannou, S. Yiannis
    Ellard, Sian
    Hattetrsley, T. Andrew
    Scordis, Nikos
    HORMONE RESEARCH, 2008, 70 : 208 - 208
  • [8] Permanent neonatal diabetes due to KCNJ11 gene mutation
    S. Letha
    Darly Mammen
    Joseph J. Valamparampil
    The Indian Journal of Pediatrics, 2007, 74 : 947 - 949
  • [9] Permanent neonatal diabetes due to KCNJ11 gene mutation
    Letha, S.
    Mammen, Darly
    Valamparampil, Joseph J.
    INDIAN JOURNAL OF PEDIATRICS, 2007, 74 (10): : 947 - 949
  • [10] Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2
    Zung, A
    Glaser, B
    Nimri, R
    Zadik, Z
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5504 - 5507